More than 700 ETFs launched last year, including ones that hold crypto or make leveraged bets on individual stocks like ...

"Big pharma braces for revenue headwinds as patent expiries loom" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand.

Kerala's public health system progress, high private health expenditure, rising treatment costs, and urgent recommendations ...

Shares of Pfizer offer a yield above 7% at recent prices. Pfizer is a pharmaceutical giant that has raised its dividend every ...

Lululemon has sued Costco, alleging the retailer sells low-cost athleisure apparel knockoffs that unlawfully infringe ...

More recently still, we've heard that the foldable iPhone might be delayed from late 2026 until early 2027, and some analysts ...

Biocon share price gained 2.5 per cent after reports suggested that the company is planning to file for generic versions of ...

The Bengaluru-based company is seeking approval of generic Ozempic by September from Canadian authorities, and also in some ...

The Bengaluru-based company is seeking approval of generic Ozempic by September from Canadian authorities, and also in some ...

The suit seeks a jury trial and for the court to order Costco to pay Lululemon damages in the form of lost profits, an order ...

In an exclusive interview with Swissinfo, Gilbert Ghostine, the chair of the board of pharma firm Sandoz, says he remains optimistic despite looming ...